Can we measure whether asthma guidelines lead to improved care?

{"article_title":"Can we measure whether asthma guidelines lead to improved care?","author":"\"Tan, Ronnie , Murphy, Anna , Brightling, Chris , Shaw, Dominick\"","journal_title":"NPJ primary care respiratory medicine","issn":"2055-1010 ; Electronic","isbn":"","publication_date":"20240627","volume":"34","issue":"1","first_page":"16","page_count":"","accession_number":"38937520","doi":"10.1038\/s41533-024-00379-6","publisher":"Nature Publishing Group","doctype":"Journal Article; Review","subjects":"Asthma ","interest_area":["Immunology Allergy & Inflammation"," Pulmonology"," Internal\/Family Medicine"],"abstract":"The British Thoracic Society (BTS) and Scottish Intercollege Guidelines Network (SIGN), as well as National Institute for Health and Care Excellence (NICE), have previously produced separate asthma guidance differing in some key aspects in diagnosis and management leading to confusion, potentially hampering guideline dissemination and uptake. While there are inherent challenges, the upcoming release of new joint BTS\/SIGN\/NICE asthma guidance presents an opportunity to assess guideline adoption and its impact on clinical practice. The use of prescription data via databases such as OpenPrescribing can be used as a surrogate for guideline adoption and potentially linked to clinical outcomes such as hospital episode statistics (HES). The potential recommendation for anti-inflammatory reliever therapy (AIR) and maintenance and reliever therapy (MART) with inhaled corticosteroid\/formoterol combination therapy in the next iteration of UK asthma guidance will require the accurate coding for the respective therapeutic approaches on prescribing platforms in order to assess their impact in real-life clinical practice. This could then direct targeted measures to improve wider guidance adoption leading to better clinical care in asthma based on up to date evidence.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=38937520&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Tan R, Murphy A, Brightling C, Shaw D","Journal_Info":"Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101631999 Publication Model: Electronic Cited Medium: Internet ISSN: 2055-1010 (Electronic) Linking ISSN: 20551010 NLM ISO Abbreviation: NPJ Prim Care Respir Med Subsets: MEDLINE","Publication_Type":"Journal Article; Review","Published_Date":"2024-06-27","Source":"NPJ primary care respiratory medicine [NPJ Prim Care Respir Med] 2024 Jun 27; Vol. 34 (1), pp. 16. Date of Electronic Publication: 2024 Jun 27.","Languages":"English","Electronic_ISSN":"2055-1010","MeSH_Terms":"Asthma*\/drug therapy , Asthma*\/therapy , Asthma*\/diagnosis , Practice Guidelines as Topic*, Humans ; United Kingdom ; Anti-Asthmatic Agents\/therapeutic use ; Guideline Adherence ; Adrenal Cortex Hormones\/therapeutic use","Subjects":"Humans, United Kingdom, Anti-Asthmatic Agents therapeutic use, Guideline Adherence, Adrenal Cortex Hormones therapeutic use, Asthma drug therapy, Asthma therapy, Asthma diagnosis, Practice Guidelines as Topic","Title_Abbreviations":"NPJ primary care respiratory medicine","Volume":"34"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"38937520","RelevancyScore":"924","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"924.316223144531"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=38937520&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=38937520&authtype=shib&custid=ns346513&group=main&profile=eds"}